Compounds > nifedipine

nifedipine and pranidipine

nifedipine has been researched along with pranidipine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's4 (40.00)18.2507
2000's3 (30.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, S; Chang, CC; Dunne, SF; Kai, L; Kang, S; Luan, CH; Pandey, P; Silverman, RB; Surmeier, DJ; Tian, X1
Kase, N; Kita, H; Uematsu, T; Yamaura, T1
Fukutani, T; Ikawa, H; Kase, N; Mizutani, H; Watanabe, D; Yamaura, T1
Fujiki, H; Hirano, T; Miyakoda, G; Mori, T; Ohura, M; Orito, K1
Nakagawa, M; Sasaki, S1
Ishizaki, T; Kudo, S; Miyamoto, G; Okumura, H1
Kimura, R; Uchida, S; Urayama, A; Yamada, S1
Fukuo, K; Morimoto, S; Niinobu, T; Ogihara, T; Suhara, T; Yang, J1
Koga, K; Mori, T; Ohura, M; Sogabe, T; Tominaga, M; Yabuuchi, Y1
Hara, H; Sasaoka, M; Shimazawa, M; Sugiyama, T; Toriu, N1

Reviews

1 review(s) available for nifedipine and pranidipine

ArticleYear
[Calcium channel blocker for therapy of patients with hypertension].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:8

    Topics: Benzimidazoles; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Thiazoles

1997

Other Studies

9 other study(ies) available for nifedipine and pranidipine

ArticleYear
Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2.
    Bioorganic & medicinal chemistry, 2010, May-01, Volume: 18, Issue:9

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Dicarboxylic Acids; Dihydropyridines; Humans; Inhibitory Concentration 50; Molecular Structure; Nifedipine

2010
Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:1

    Topics: Anesthesia, General; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Guinea Pigs; Heart; Heart Rate; Hemodynamics; Hypertension, Renal; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Rabbits; Rats; Rats, Inbred Strains

1986
Polymorphism of methyl (E)-3-phenyl-2-propen-1-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate (FRC-8411).
    Chemical & pharmaceutical bulletin, 1986, Volume: 34, Issue:11

    Topics: Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry, Physical; Crystallization; Dihydropyridines; Male; Nifedipine; Rats; Rats, Inbred SHR; X-Ray Diffraction

1986
Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
    European journal of pharmacology, 1997, Apr-18, Volume: 324, Issue:2-3

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Injections, Intravenous; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Venous Pressure

1997
Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine.
    Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:2

    Topics: Biotransformation; Calcium Channel Blockers; Cell Line; Chromatography, High Pressure Liquid; Coenzymes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; DNA, Complementary; Enzyme Inhibitors; Humans; Isoenzymes; Microsomes, Liver; Nicotinic Acids; Nifedipine

1999
In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.
    Pharmacology, 1999, Volume: 59, Issue:4

    Topics: Algorithms; Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels, L-Type; Cerebral Cortex; Dihydropyridines; Isradipine; Male; Myocardium; Nifedipine; Rats; Rats, Inbred SHR

1999
Pranidipine enhances the action of nitric oxide released from endothelial cells.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 1

    Topics: Amlodipine; Animals; Aorta, Thoracic; Calcium Channel Blockers; Cells, Cultured; Coculture Techniques; Cyclic GMP; Dihydropyridines; Endothelin-1; Endothelium, Vascular; Humans; Hypertension; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Superoxide Dismutase

2000
Venodilatory effect of pranidipine, a calcium channel blocker, monitored with perfluorocarbon in vivo (19)F-NMR spectroscopy.
    Magnetic resonance imaging, 2000, Volume: 18, Issue:8

    Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Fluorine; Fluorocarbons; Hemodynamics; Laser-Doppler Flowmetry; Magnetic Resonance Spectroscopy; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Time Factors; Vasodilator Agents; Veins

2000
Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve head of rabbits.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:2

    Topics: Animals; Blood Circulation; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Ciliary Arteries; Dihydropyridines; Dose-Response Relationship, Drug; Endothelin-1; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Nifedipine; Optic Disk; Piperazines; Rabbits; Regional Blood Flow

2001